John P. Longenecker

733 total citations
17 papers, 613 citations indexed

About

John P. Longenecker is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, John P. Longenecker has authored 17 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cancer Research. Recurrent topics in John P. Longenecker's work include Cancer, Hypoxia, and Metabolism (4 papers), Diet, Metabolism, and Disease (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). John P. Longenecker is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Diet, Metabolism, and Disease (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). John P. Longenecker collaborates with scholars based in Australia, United States and Poland. John P. Longenecker's co-authors include John F. Williams, Lorin K. Johnson, Deborah A. Eppstein, Linda K. Johnson, Krishan K. Arora, Robert D. Silver, Edward J. Dubovi, Alan C. Moses, Jeffrey S. Flier and Martin C. Carey and has published in prestigious journals such as The Journal of Cell Biology, Biochemical Journal and Trends in Biochemical Sciences.

In The Last Decade

John P. Longenecker

16 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Longenecker Australia 12 214 181 122 84 80 17 613
John Armstrong United States 11 226 1.1× 59 0.3× 85 0.7× 68 0.8× 105 1.3× 19 820
A D Habberfield United Kingdom 12 508 2.4× 59 0.3× 111 0.9× 177 2.1× 181 2.3× 20 778
Ruth G. Doell United States 10 216 1.0× 38 0.2× 131 1.1× 140 1.7× 143 1.8× 16 764
Orville F. Denstedt Canada 17 260 1.2× 25 0.1× 84 0.7× 258 3.1× 131 1.6× 57 669
Duncan R. Paton United States 12 226 1.1× 123 0.7× 23 0.2× 8 0.1× 80 1.0× 14 495
John M. Yanni United States 23 246 1.1× 56 0.3× 15 0.1× 199 2.4× 16 0.2× 52 1.6k
Xiaowei Ma China 11 249 1.2× 32 0.2× 65 0.5× 114 1.4× 67 0.8× 24 606
Xunsheng Chen United States 17 399 1.9× 13 0.1× 45 0.4× 106 1.3× 79 1.0× 28 767
B. A. Gordon Canada 14 254 1.2× 12 0.1× 30 0.2× 211 2.5× 62 0.8× 47 616

Countries citing papers authored by John P. Longenecker

Since Specialization
Citations

This map shows the geographic impact of John P. Longenecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Longenecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Longenecker more than expected).

Fields of papers citing papers by John P. Longenecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Longenecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Longenecker. The network helps show where John P. Longenecker may publish in the future.

Co-authorship network of co-authors of John P. Longenecker

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Longenecker. A scholar is included among the top collaborators of John P. Longenecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Longenecker. John P. Longenecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Longenecker, John P., et al.. (1994). The Bioavailability of Intranasal Salmon Calcitonin in Healthy Volunteers with and Without a Permeation Enhancer. Pharmaceutical Research. 11(5). 747–750. 59 indexed citations
2.
Taboga, Claudio, Elizabeth Salamon, A C Moses, et al.. (1990). Biological Activity of Nasally Administered Insulin in Normal Subjects. Hormone and Metabolic Research. 22(3). 170–174. 35 indexed citations
3.
Baldwin, Patricia A., et al.. (1990). The Effect of Sodium Tauro-24,25-Dihydrofusidate on the Nasal Absorption of Human Growth Hormone in Three Animal Models. Pharmaceutical Research. 7(5). 547–552. 53 indexed citations
4.
Eppstein, Deborah A. & John P. Longenecker. (1988). Alternative delivery systems for peptides and proteins as drugs.. PubMed. 5(2). 99–139. 57 indexed citations
5.
Williams, John F., Krishan K. Arora, & John P. Longenecker. (1987). The pentose pathway: A random harvest. International Journal of Biochemistry. 19(9). 749–817. 42 indexed citations
6.
Longenecker, John P., Alan C. Moses, Jeffrey S. Flier, et al.. (1987). Effects of Sodium Taurodihydrofusidate on Nasal Absorption of Insulin in Sheep. Journal of Pharmaceutical Sciences. 76(5). 351–355. 103 indexed citations
7.
Arora, Krishan K., John P. Longenecker, & John F. Williams. (1987). Mechanism and quantitative contribution of the pentose pathway to the glucose metabolism of Morris Hepatoma 5123C. International Journal of Biochemistry. 19(2). 133–146. 7 indexed citations
8.
Longenecker, John P., et al.. (1984). Glucocorticoid inhibition of vascular smooth muscle cell proliferation: influence of homologous extracellular matrix and serum mitogens.. The Journal of Cell Biology. 98(2). 534–540. 48 indexed citations
9.
Williams, John F., Krishan K. Arora, & John P. Longenecker. (1983). The F-pentose cycle doesn't have the answers for liver tissue. Trends in Biochemical Sciences. 8(8). 275–277. 9 indexed citations
10.
Longenecker, John P., et al.. (1982). Glucocorticoid influence on growth of vascular wall cells in culture. Journal of Cellular Physiology. 113(2). 197–202. 54 indexed citations
11.
Johnson, Lorin K. & John P. Longenecker. (1982). Senescence of aortic endothelial cells in vitro: Influence of culture conditions and preliminary characterization of the senescent phenotype. Mechanisms of Ageing and Development. 18(1). 1–18. 36 indexed citations
12.
Johnson, Linda K., John P. Longenecker, John D. Baxter, et al.. (1982). Glucocorticoid action: a mechanism involving nuclear and non-nuclear pathways. British Journal of Dermatology. 107(s23). 6–23. 42 indexed citations
13.
Longenecker, John P. & John F. Williams. (1981). An enzymatic method for the preparation in high yield of [5‐14C]‐ and [4,5,6‐14C] glucose. Journal of Labelled Compounds and Radiopharmaceuticals. 18(3). 309–317. 7 indexed citations
14.
Longenecker, John P. & John F. Williams. (1980). Use of [2-14C]glucose and [5-14C]glucose for evaluating the mechanism and quantitative significance of the ‘liver-cell’ pentose cycle. Biochemical Journal. 188(3). 847–857. 26 indexed citations
15.
Longenecker, John P. & John F. Williams. (1980). Quantitative measurement of the L-type pentose phosphate cycle with [2-14C]glucose and [5-14C]glucose in isolated hepatocytes. Biochemical Journal. 188(3). 859–865. 31 indexed citations
16.
Longenecker, John P. & John F. Williams. (1978). Globin messenger RNA content in hepatomas: a test of retrogenesis. Cancer Letters. 4(1). 45–49. 1 indexed citations
17.
Longenecker, John P. & John F. Williams. (1977). A MECHANISM OF TUMOURIGENESIS RETRODIFFERENTIATION AND REONTOGENY IN CANCER AND ITS CLINICAL SIGNIFICANCE. The Medical Journal of Australia. 2(8). 237–239. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026